Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease: COMMENTARY

Reichen, Juerg
January 2006
ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p22
Academic Journal
The article presents comments on a clinical study to assess the effect of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) on survival in a large number of patients. They found that mortality was increased by 34% in NAFLD and that age, IFG, and cirrhosis were predictors of mortality. 13 patients developed liver-related complications. The authors rightfully pointed out that their data were more representative of the general population than previous reports and that the mortality rate from liver disease was lower than in cohorts from hepatology centers. First, the cohort consisted of 420 patients, although greater than 42 000 patients may be affected by NAFLD/NASH, based on the postulated prevalence of 34% in the population of 124 000 persons in Olmsted county. A question that remains unanswered for the internist and general practitioner is what to do with the patient with marker-negative liver disease who is suspected of having NAFLD/NASH.


Related Articles

  • Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization. Patidar, Kavish R; Sterling, Richard K; Sanyal, Arun J; Siddiqui, Mohammad S; Matherly, Scott C; Stravitz, R Todd; Puri, Puneet; Luketic, Velimir A; Fuchs, Michael; White, Melanie B; Noble, Nicole A; Unser, Ariel B; Gilles, HoChong; Heuman, Douglas M; Bajaj, Jasmohan S; Thacker, Leroy R; Wade, James B // American Journal of Gastroenterology;Nov2014, Vol. 109 Issue 11, p1757 

    OBJECTIVES:Despite the high prevalence of covert hepatic encephalopathy (CHE) in cirrhotics without previous overt HE (OHE), its independent impact on predicting clinically relevant outcomes is unclear. The aim of this study was to define the impact of CHE on time to OHE, hospitalization, and...

  • Betaine: An Old Therapy for a New Scourge. Neuschwander-Tetri, Brent A. // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2534 

    Deals with the efficacy of betaine as a practical therapeutic agent. Salutary effects of betaine on the biochemical and the histological abnormalities of nonalcoholic steatohepatitis (NASH); Sources and important biological activity of betaine; Value of dietary betaine in preventing...

  • HEPATITIS: WHAT YOU SHOULD KNOW.  // Body Bulletin;Nov2003, Vol. 4 Issue 11, p5 

    The article focuses on Hepatitis. At least 5 different contagious viruses can cause inflammation of the liver. Hepatitis A, B, and C are the most common types, while D and E are other less common forms. Symptoms of infection may be mild, absent initially or start suddenly with fever, abdominal...

  • Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease. Yongli Wei; Qing Tian; Xiuxia Zhao; Xingchun Wang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 3, p4545 

    Transforming growth factor beta 3 (TGFb3) was mainly expressed by liver satellite cells in the normal liver, but it may be expressed by various liver cells during liver diseases, e.g. hepatitis and cirrhosis. However, whether TGFb3 level may be used to predict development of nonalcoholic fatty...

  • Prognostic Factors in Alcoholic Liver Disease. Chedid, Antonio; Mendenhall, Charles L.; Gartside, Peter; French, Samuel W.; Chen, Thomas; Rabin, Lionel // American Journal of Gastroenterology;Feb1991, Vol. 86 Issue 2, p210 

    Two hundred eighty-one alcoholic patients were prospectively evaluated by clinical, biochemical, and histologic parameters during a 4-yr period to assess their prognosis. They were stratified into four categories of injury; 1) fatty liver (26 patients), 2) acute alcoholic...

  • Enfermedad por hígado graso no alcohólico en pediatría. Bojórquez-Ramos, María del Carmen // Revista Medica del IMSS;ene/feb2014 Supplement, Vol. 52, pS110 

    Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of liver disease in children and adolescents in the United States of America (USA) and probably in the entire western hemisphere, due to the increase in the prevalence of overweight and obesity. Steatosis can progress to...

  • The Pervading Influence of Alcoholic Liver Disease in Hepatology. Williams, Roger // Alcohol & Alcoholism;Jul/Aug2008, Vol. 43 Issue 4, p393 

    Rising levels of alcohol consumption in the UK are leading to substantial increases in morbidity and mortality from liver disease. Drinking is starting at an earlier age with binging an increasing common pattern, and women are overtaking men in the consumption. Manifestations of liver damage...

  • Hypertrophic osteoarthropathy in a child with chronic liver disease. Kock, C.; Terblanche, A. J.; Wittenberg, D. F. // South African Journal of Child Health;May2014, Vol. 8 Issue 2, p80 

    Hypertrophic osteoarthropathy (HOA) is an uncommon condition in children, consisting of a triad of digital clubbing, non-inflammatory joint effusions and radiographic evidence of periostitis affecting the hands, feet and distal long bones. HOA is classified as primary (idiopathic) or secondary...

  • Overlap and other autoimmune phenomena in pediatric chronic hepatic disease. Pacurar, Daniela; Lesanu, Gabriela; Becheanu, Cristina; Vlad, Raluca; Oraseanu, Dumitru // Romanian Journal of Pediatrics;2012, Vol. 61 Issue 2, p148 

    Patients with chronic liver disease can present serological immune associations or a real overlap syndrome. The hepatic overlap syndrome includes biochemical and histological features either for two autoimmune hepatic diseases or for one autoimmune hepatitis and another chronic hepatic disease...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics